[HTML][HTML] The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review

A Roshanshad, A Kamalipour, MA Ashraf… - Iranian Journal of …, 2020 - ncbi.nlm.nih.gov
Materials and Methods: We performed a systematic search in Pubmed, Embase, Web of
Science, Google scholar and MedRxiv for relevant observational and interventional studies …

Effects of Remdesivir in Hospitalized patients with COVID-19: systematic review and Individual Patient Data Meta-Analysis of Randomized clinical trials

A Amstutz, B Speich, F Mentré, CS Rueegg, D Belhadi… - 2022 - papers.ssrn.com
Background: The evidence from randomized trials on remdesivir for hospitalized patients
with coronavirus disease 2019 (COVID-19) is conflicting. We conducted a systematic review …

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

WC Ko, JM Rolain, NY Lee, PL Chen, CT Huang… - International journal of …, 2020 - Elsevier
Since the end of 2019, an increasing number of cases of pneumonia were reported in
Wuhan, followed by other cities and provinces in China and many other countries …

Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial

H Hosseini, A Sadeghi, P Tabarsi, A Etemadimanesh… - MedRxiv, 2021 - medrxiv.org
Introduction After emerging the global pandemic of SARS-CoV2 some preliminary studies
demonstrated the efficacy of antiviral treatments. But shortly thereafter, inconsistencies in the …

The place for remdesivir in COVID-19 treatment

B Young, TT Tan, YS Leo - The Lancet Infectious Diseases, 2021 - thelancet.com
Finding antivirals that reduce mortality from severe respiratory viral infections has proven
challenging. Phase 3 trials of baloxavir and pimodivir for severe influenza were …

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

A Amstutz, B Speich, F Mentré, CS Rueegg… - The Lancet …, 2023 - thelancet.com
Background Interpretation of the evidence from randomised controlled trials (RCTs) of
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …

[HTML][HTML] A meta-analysis of association between remdesivir and mortality among critically-ill COVID-19 patients

AA Razzack, SA Hassan, SKR Pasya… - Infection & …, 2021 - ncbi.nlm.nih.gov
Background The World Health Organization guidelines did not make a recommendation on
use of remdesivir based on disease severity. Little is known regarding effectiveness of …

[HTML][HTML] Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected …

L Pilgram, KS Appel, MM Ruethrich, CEM Koll… - Infection, 2023 - Springer
Objectives The use of remdesivir (RDV) as the first drug approved for coronavirus disease
2019 (COVID-19) remains controversial. Based on the Lean European Open Survey on …

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis

MT Angamo, MA Mohammed, GM Peterson - Infection, 2022 - Springer
Purpose This review was aimed to synthesise the best available evidence on the
effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19 …

Remdesivir for severe covid-19: a clinical practice guideline

B Rochwerg, A Agarwal, L Zeng, YS Leo, JA Appiah… - bmj, 2020 - bmj.com
Clinical question What is the role of remdesivir in the treatment of severe covid-19? This
guideline was triggered by the ACTT-1 trial published in the New England Journal of …